Rinofima: una revisión de la literatura

Article Sidebar

PDF (Español (España))
Published: Sep 24, 2018
DOI: https://doi.org/10.37076/acorl.v40i3.213

Main Article Content

Jorge Alberto Espinosa Reyes
Hospital Militar Central, Bogotá, D. C., Colombia.
Diana Patricia Parra Valencia
Hospital Militar Central.

Abstract

El rinofima, a pesar de no ser una entidad común, sí es una patología que altera en forma importante la estética facial del individuo; por tal razón, su entendimiento, adecuado diagnóstico y terapia precisa son de gran relevancia para lograr la mejor recuperación posible. Entre las opciones de manejo existen múltiples herramientas, que van desde la prevención hasta procedimientos quirúrgicos agresivos. A pesar de lo anterior, los pacientes con rosácea, condición patológica inicial, avanzan por los diferentes estadios de la evolución de la enfermedad sin tratamiento médico adecuado, y terminan en el rinofima, condición final del proceso patológico. El objetivo de este artículo fue realizar una revisión de la literatura actual del tema..

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Espinosa Reyes JA, Parra Valencia DP. Rinofima: una revisión de la literatura. Acta otorrinolaringol cir cabeza cuello [Internet]. 2018Sep.24 [cited 2024Nov.10];40(3):220-7. Available from: https://dev.revista.acorl.org.co/index.php/acorl/article/view/213
Issue
Vol. 40 No. 3 (2012): Julio - Septiembre
Section
Revisiones

Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.

Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.

Author Biographies

Jorge Alberto Espinosa Reyes, Hospital Militar Central, Bogotá, D. C., Colombia.

Cirujano Plástico Facial-Otorrinolaringólogo, Hospital Militar Central, Bogotá, D. C., Colombia.

Diana Patricia Parra Valencia, Hospital Militar Central.

Residente de IV nivel de Otorrinolaringología, Hospital Militar Central.

References

Cello J, Hernández D. Rinofima. Tratamiento quirúrgico con el uso de radiofrecuencia. Cir Plast, 2007; 17 (3):176-180.

Winston C, Crabtree. Rhinophyma. California and Western Medicine, 1936; 45: 485-487.

Sams, Wiley M. Diseases of the skin. Arch Dermat and Syph, 1936, 26: 836-841.

Rohrich RJ, Griffin JR, Adams WP Jr. Rhinophyma: review and update. Plast Reconstr Surg, 2002; 110: 860-870.

Gil M, Boixeda J. Rosácea: revisión y nuevas alternativas terapéuticas. Semergen, 2011; 37 (2): 83-86.

Webster G. Rosacea. Med Clin N Am, 2009; 93: 1183-1194.

Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol, 1989; 69: 419-23.

Katz AM. Rosacea: epidemiology and pathogenesis. J Cut Med Surg, 1998; 2 (suppl. 4): 4-9.

Berstein JE, Soltani K. Alcohol - induced rosacea rubefaction blocked by naloxone. Br J Dermatol, 1982; 107: 59-62.

Orjuela P, Mendoza N. Rosácea. Centro Dermatológico Federico Lleras Acosta, 1998.

Aaron F, Cohen. Diagnosis and treatment of Rosacea. J Am Board Fam Pract, 2002; 15: 214-7.

Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol, 1969; 100: 686-92.

Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol, 1994; 89: 1603-4.

Utas S, Ozbakir O, Turasan A, et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol, 1999; 40: 433-5.

Hirschman JV. Does Helicobacter pylori have a role in the pathogenesis of rosacea? J Am Acad Dermatol, 2000; 42: 537-39.

Bamford JT, Tilden R, Blankush J, Gangeness DE. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol, 1999; 135: 659-63.

Goldman D. Tacrolimus ointment for the treatment of steroid induced rosacea, a preliminary report. J Am Acad Dermatol, 2001; 44: 995-9.

Bernard LA, Cunningham BB, Al-Suwaidan S, Friedlander SF, Eichenfield LF. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Arch Dermatol, 2003; 139 (2): 229-231.

Jaramillo MJ, Stewart KJ, Kolhe PS. Phenytoin induced rhinophyma treated by excision and full thickness skin grafting. Br J Plast Surg, 2000; 53: 521-523.

Erbagci Z, Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol, 1998; 37: 421-5.

Roihu T, Kariniemi AL. Demodex mites in rosacea. J Cutan Pathol, 1998; 25: 550-2.

Zuber TJ. Rosacea. Dermatology. Prim Care, 2000; 27: 309-18.

Aloi F, Tomasini C, Soro E, Pippione M. The clinic pathologic spectrum of rhinophyma. J Am Acad Dermatol, 2000; 42 (3): 468-472.

Powell FC. Rosacea. N Engl J Med, 2005; 352 (8): 793-803.

Wilkin JK. Rosacea [review]. Int J Dermatol, 1983; 22: 393-400.

Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol, 1994; 130: 359-62.

Thiboutout D. Acne and rosacea. Dermatol Clin, 2000; 18: 63-71.

Ryan TJ. Structure and function of lymphatics. J Invest Dermatol, 1989; 93: 18s-24s.

Wilkin J, Detmar M, Drake L, et al. Standard classification of rosacea. J Am Acad Dermatol, 2002; 46.

Kligman AM. Ocular rosacea. Current concepts and therapy. Arch Dermatol, 1997; 133: 89-90.

Stone DU, Chodosh J. Ocular rosacea an update on pathogenesis and therapy. Curr Opin Ophthalmol, 2004; 15: 499-502.

Murray AH. Differential diagnosis of a red face. J Cutan Med Surg, 1998; 2 (Suppl 4): 11-5.

Freeman BS. Reconstructive rhinoplasty for rhinophyma. Plast Reconstr Surg, 1970; 46: 265-70.

Wei Lim S, Bekhor P. Rhinophyma: Carbon dioxide laser with computerized scanner is still an outstanding treatment. Australasian Journal of Dermatology, 2009; 50: 289-295.

Serrano C, Serrano S. Indicaciones actuales de la dermoabrasión. Cir Dermt, 2008; 23 (9): 514-8.

Seelig, MG. Surgical Clinics of North America, 5:1385.

New, Gordon: Surgical Clinics of North America, 1: 1395.

Del Rosso JQ. Systemic therapy for rosacea, focus on oral antibiotictherapy and safety. Cutis, 2000; 66: 7-13.

Wilkin JK. Use of topical products for maintaining remission in rosacea. Arch Dermatol, 1999; 135: 79-82.

Breneman DL, Stewart D, Hevia O, Hino PD, Drake LA. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis, 1998; 61: 44-7.

Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol, 1998; 134: 679-83.

Wereide K. Long term treatment of rosacea with oral tetracycline. Acta Derm Venereol, 1969; 49: 176-9.

Bikowski JB. Treatment of rosacea with doxycycline monohydrate. Cutis, 2000; 66: 149-52.

Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol, 1999; 40 (6 Pt 1): 961-5.

Bakar O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol, 2004; 43 (2): 151-154.

Hoting E, Paul E, Plewing G. Treatment of rosacea with isotretinoin. Int J Dermatol, 1986; 25: 660-3.

Carlin RB, Carlin CS. Topical vitamin C preparation reduces erythema of rosacea. Cosmetic Dermatol, 2001; Feb: 35-8.

Bogetti P, Boltri M, Spagnoli G, Dolcet M. Surgical treatment of rhinophyma: a comparison of techniques. Aesthetic Plast Surg., 2002; 26: 57-60.

Brightman L, Brauer J. Ablative and Fractional Ablative Lasers. Dermatol Clin, 2009; 27: 479-489.

Hsu CK, Lee JY, Wong TW. Good cosmesis of a large rhinophyma after carbon dioxide laser treatment. J Dermatol, 2006; 33: 227-9.

Simo R, Sharma VL. Treatment of rhinophyma with carbon dioxide laser. J Laryngol Otol, 1996; 110: 841-6.

El-Azhary RA, Roenigk RK, Wang TD. Spectrum of results after treatment of rhinophyma with the carbon dioxide laser. Mayo Clin Proc, 1991; 66: 899-905.

Neuhaus IM, Zane LT, Tope WD. Comparative Efficacy of Nonpurpuragenic Pulsed Dye Laser and Intense Pulsed Light for erithematotelangiectatic Rosacea. Dermatol Surg, 2009; 35:920-8.

West TB, Alster TS. Comparison of the long pulse dye (590595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Derm Surg, 1998; 24: 510-2.

Patrick KY, Milind D, Francis CP. The gold standard for decortication of rhinophyma: combined erbium-YAG/CO2 Laser. Aesth Plast Surg, 2004; 28: 456-460.

Tanzi EL, Alster TS. Single-pass carbon dioxide versus multiple-pass Er: YAG laser skin resurfacing: a comparison of postoperative wound healing and side-effect rates. Dermatol Surg, 2003; 29: 80-4.

Orenstein A, Haik J, Tamir J, Winkler E, Frand J, Zilinsky I, Kaplan H. Treatment of rhinophyma with Er: YAG laser. Lasers Surg Med, 2001; 29: 230-5.

Greenbaum SS, Krull EA, Watnick K. Comparison of CO2 laser and electrosurgery in the treatment of rhinophyma. J Am Acad Dermatol, 1988; 18: 363-8.

Aferzon M, Millman B. Excision of rhinophyma with high frequency electro-surgery. Dermatol Surg, 2002; 28: 735-8.

Most read articles by the same author(s)